Company / Assets per Share
Tvardi Therapeutics, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.65
FY2024
5-year range
$2.34 / $9.65
FY2020-FY2024
Trend
+312.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +313% YoY in FY2024, a notable deviation from the 9-year average annual change of +33%.
Based on SEC 10-K filings.
9.65 in FY2024 with a 5-year CAGR of +10.4%.
Improved from $3.41 to $9.65 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +24.9%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, assets per share increased 312.7% year-over-year.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.65 | +312.7% |
| FY2023 | $2.34 | -31.4% |
| FY2022 | $3.41 | -31.2% |
| FY2021 | $4.95 | -14.6% |
| FY2020 | $5.80 | -1.5% |
| FY2019 | $5.89 | +0.8% |
| FY2018 | $5.84 | +64.4% |
| FY2017 | $3.55 | +51.7% |
| FY2016 | $2.34 | -51.8% |
| FY2015 | $4.86 | -62.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026